IRIS
MILANESE, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.879
Totale 13.879
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.879
Totale 13.879
Salva come PNG Salva come JPEG
Città #
Genova 9.343
Genoa 1.882
Rapallo 1.492
Vado Ligure 1.122
Bordighera 40
Totale 13.879
Salva come PNG Salva come JPEG
Nome #
Acute stress increases depolarization-evoked glutamate release and presynaptic SNARE complex accumulation in prefrontal/frontal cortex. The dampening action of antidepressants. 162
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 161
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways 157
CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice 155
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 155
Altered intracellular calcium homeostasis underlying enhanced glutamatergic transmission in striatal-enriched tyrosine phosphatase (STEP) knockout mice 150
Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 144
Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease 143
Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis. 138
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosis at a Pre-Symptomatic Stage of the Disease. 133
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 132
Chronic mild stress induces anhedonic behavior and changes in glutamate release, BDNF trafficking and dendrite morphology only in stress vulnerable rats. The rapid restorative action of ketamine 131
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes 130
Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord 126
The high-mobility group box 1 cytokine induces transporter-mediated release of glutamate from glial subcellular particles (gliosomes) prepared from in situ-matured astrocytes 126
The P2X7 receptor as a route for non-exocytotic glutamate release: dependence on the carboxyl tail 126
The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release 125
Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain 124
Enriched experience and recovery from amblyopia in adult rats: impact of motor, social and sensory components. 122
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone 122
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 122
Colocalization of neurotransmitter transporters on the plasma membrane of the same nerve terminal may reflect cotransmission. 121
Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down Syndrome. 120
Sox2 conditional mutation in mouse causes ataxic symptoms, cerebellar vermis hypoplasia, and postnatal defects of Bergmann glia 118
DIABETIC NEUROPATHIC PAIN: A ROLE FOR TESTOSTERONE METABOLITES 117
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis 116
Differential expression of metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals 115
Synthesis and evaluation of resins bearing substrate-like inhibitor functions for capturing copper amine oxidases 114
Role of calpain-1 in the early phase of experimental ALS 112
Environmental therapy for cognitive and sensory impairment in a mouse model of Down syndrome 111
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 110
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings 109
Neurounina-1, a Novel Compound that Increases Na+/Ca2+ Exchanger Activity, Effectively Protects Against Stroke Damage 109
Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by ‘pathologically’ elevated extraterminal K+ concentrations 108
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. 107
A New Function for Glycine GLYT2 Transporters: Stimulation of GABA Release from Cerebellar Nerve Terminals Through GAT-1 Transporter Reversal and Ca2+-Dependent Anion Channels 105
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex 105
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein 105
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 105
Glutamate release from astrocytic gliosomes under physiological and pathological conditions 103
CCL5-glutamate crosstalk and presynaptic defects in EAE mice 103
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 103
Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synapticplasticity, and visual functions in a mouse model of Down syndrome 102
Intravenous mesenchymal stem cells improve survival and motor functions in symptomatic mutant SOD1/G93A mice 101
Increased [3H]D-aspartate release and changes in glutamate receptor expression in the hippocampus of the mnd mouse. 100
Metabotropic glutamate receptor 5 as a potential target in ALS 100
Abnormal and precocious exocytotic glutamate release in a mouse model of amyotrophic lateral sclerosis 99
Unusual increase in lumbar network excitability of the rat spinal cord evoked by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake. 99
Ketamine modulates glutamate release, BDNF trafficking and dendrite morphology in rats vulnerable to chronic mild stress 99
Synaptic mechanisms underlying the excessive and precocious glutamate release in the spinal cord of sod1g93a mice. 98
mGluR1 and mGluR5 knock-down improves survival, motor skills and disease progression in amyotrophic lateral sclerosis mouse model 98
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone. 97
GroupI metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 97
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression 97
Fluoxetine treatment promotes functional recovery in a rat model of cervical spinal cord injury 96
Proteomic analysis of gliosomes from mouse brain: identification and investigation of glial membrane proteins 96
Impairment of Neuronal Glutamate Uptake and Modulation of the Glutamate Transporter GLT-1 Induced by Retinal Ischemia 94
Adult astroglia is competent for Na+/Ca2+ exchanger-operated exocytotic glutamate release triggered by mild depolarization 93
Diabetic neuropathic pain: a role for testosterone metabolites 93
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis 93
Knocking-down mGlu1 receptors prolongs survival and ameliorates disease progression in the SOD1/G93A mouse model of ALS. 92
Acute stress and corticosterone increase the readily releasable pool of glutamatergic vesicles in rat synaptosomes of prefrontal/frontal cortex via mineralocorticoid and glucocorticoid receptors 91
Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS 91
Targeting Group I Metabotropic Glutamate Receptors in Amyotrophic Lateral Sclerosis 90
Agomelatine reduces glutamate release induced by acute stress, possible synergism between melatonin and 5HT2C properties 90
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 87
Gamma-amino butyric acid (GABA) release in the ciliated protozoon Paramecium occurs by neuronal-like exocytosis 86
GROUP I METABOTROPIC GLUTAMATE RECEPTORS AND NEUROTOXICITY IN AMYOTROPHIC LATERAL SCLEROSIS 86
Release of [3H]D-aspartate induced by K+-stimulation is increased in the cervical spinal cord of wobbler mice, a model of motor neuron disease. 84
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 84
Group I metabotropic glutamate receptors tune excitotoxicity in amyotrophic lateral sclerosis 84
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 84
Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis 84
GLUTAMATE NEUROTRANSMISSION IS MODIFIED IN THE SOD1/G93A MOUSE MODEL OF ALS 83
Acute ketamine restores deficits in glutamate release and related molecular mechanisms induced by chronic mild stress in vulnerable rats 83
Presynaptic mechanisms mediating the increase of glutamate release induced by acute stress in prefrontal cortex 82
Astrocyte contribution to the excessive glutamate release in the spinal cord of the SOD1G93A mouse model of amyotrophic lateral sclerosis 82
Ketamine restores changes in glutamate release, dendrite morphology and BDNF trafficking in the hippocampus of rats vulnerable to chronic mild stress 82
Targeting group i metabotropic glutamate receptors in experimental als. 82
Cognitive impairment in Gdi1 deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training 82
The novel antidepressant agomelatine reduces release of glutamate and related presynaptic mechanisms in rat hippocampus 81
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 81
Reducing the expression of mGlu1 and mGlu5 receptors ameliorates survival and disease progression in SOD1G93A mice 80
Amyotrophic lateral sclerosis and excitotoxicity: role of Group I metabotropic glutamate receptors 79
Knocking down mglu1 receptors prolongs survival and improves symptomatology in a mouse model of amyotrophic lateral sclerosis 79
The Modulation of Glutamate Release by Group I Metabotropic Glutamate Auto-Receptors in ALS 78
Group I metabotropic glutamate receptors in ALS: knocking-down mGlu1 receptors ameliorates survival and disease progression in SOD1/G93A mice. 77
Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophjagic flux. 75
The impact of stress and glucocorticoids on glutamate synapses in cerebral cortex 75
G93A mutated SOD1-linked murine ALS produces abnormal exocytotic release of glutamate 75
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosisat a Pre-Symptomatic Stage of the Disease. 75
Altered synaptic mechanisms and excessive glutamate release in amyotrophic lateral sclerosis 75
CCL5-glutamate crosstalk and presynaptic defects in EAE mice 74
Mesemchymal stem cells systemically administered in symptomatic mutant SOD1-G93A mice ameliorate survival and motor abilities 74
Genetic and pharmacological effects of mGlu5 receptor blockade in the SOD1G93A mouse model of amyotrophic lateral sclerosis 74
Partial deletion of mGluR1 receptors prolongs life span and ameliorates motor skills and biochemical and cellular parameters in a mouse model of experimental ALS 73
Non conventional activity of the endocannabinoid system at glutamate release in rat cortical astrocytes 73
Group I metabotropic glutamate receptors induce excessive glutamate release in the spinal cord of sod1g93a mice 73
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice 73
Reducing excitotoxicity knocking down mGluR1: prolonged survival and improved symptomatology of SOD1/G93A mouse model of ALS 72
Totale 10.177
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.919
article - articoli 23.855
book - libri 778
conference - conferenze 22.286
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.634 0 0 0 0 213 355 456 183 265 646 386 130
2020/20211.042 53 115 73 54 83 79 85 117 95 109 82 97
2021/20221.900 37 119 108 191 79 148 123 470 107 173 69 276
2022/20231.838 187 169 23 206 274 289 12 116 295 14 212 41
2023/20241.510 50 175 49 178 124 302 119 67 65 70 108 203
2024/20251.270 218 307 124 313 308 0 0 0 0 0 0 0
Totale 14.455